Potassium iodide
This article was originally published in The Tan Sheet
Executive Summary
"FDA is planning to conduct studies of the palatability, solubility and stability of KI dissolved in a number of different liquids, including juice and formula," agency says in Q&A document on use of the OTC in radiation emergencies. FDA notes it is working with KI manufacturers to "expedite submission and review" of applications for tablet dosage strengths below 130 mg and to amend "Drug Facts" labeling to incorporate new KI dosing recommendations announced in December (1"The Tan Sheet" Dec. 17, 2001, p. 5). Recommendations generally call for adults 18 and older to take 130 mg/day, children three and older 65 mg/d, children under three 32 mg/d...
You may also be interested in...
Potassium Iodide Stockpiling Guidelines Called For In Bioterrorism Bill
Within a year of enacting bioterrorism legislation, the Bush Administration will consult with federal, state and local agencies to establish guidelines for the stockpiling of potassium iodide (KI) tablets
Bioterrorism Preparedness Addressed On Capitol Hill, At FDA
Any facility that manufactures, processes, packs or holds food for consumption in the U.S. would have to register with HHS within 180 days of the enactment of a bioterrorism bill passed by the House Dec. 12
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.